🇺🇸 FDA
Patent

US 10463028

Genetically modified non-human animals expressing human EPO

granted A61KA61K49/0008

Quick answer

US patent 10463028 (Genetically modified non-human animals expressing human EPO) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K49/0008